BODE index
The BODE index, for Body-mass index, airflow Obstruction, Dyspnea, and Exercise, is a multidimensional scoring system and capacity index used to test patients who have been diagnosed with chronic obstructive pulmonary disease (COPD) and to predict long-term outcomes for them. The index uses the four factors to predict risk of death from the disease.
The BODE index will result in a score of zero to ten dependent upon FEV1 or "forced expiratory volume in one second" (the greatest volume of air that can be breathed out in the first second of a breath), body-mass index, the distance walked in six minutes, and the modified MRC dyspnea scale.[1] Significant weight loss is a bad sign.[2] Results of spirometry are also good predictors of the future progress of the disease, but they are not as good as the test results of the BODE index.[2][3]
References
- Medicine, prepared by the Department of Medicine, Washington University School of (2009). The Washington manual general internal medicine subspecialty consult (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 96. ISBN 978-0-7817-9155-7.
- Reilly, John J.; Silverman, Edwin K.; Shapiro, Steven D. (2011). "Chronic Obstructive Pulmonary Disease". In Longo, Dan; Fauci, Anthony; Kasper, Dennis; Hauser, Stephen; Jameson, J.; Loscalzo, Joseph (eds.). Harrison's Principles of Internal Medicine (18th ed.). McGraw Hill. pp. 2151–9. ISBN 978-0-07-174889-6.
- National Institute for Health and Clinical Excellence. Clinical guideline 101: Chronic Obstructive Pulmonary Disease. London, June 2010.
Further reading
- Celli, Bartolome R.; Cote, Claudia G.; Marin, Jose M.; Casanova, Ciro; Montes de Oca, Maria; Mendez, Reina A.; Pinto Plata, Victor; Cabral, Howard J. (2004). "The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease". N Engl J Med. 350 (10): 1005–12. doi:10.1056/NEJMoa021322. PMID 14999112.
- Mahler, D.A.; Criner, G.J. (2007). "Assessment tools for chronic obstructive pulmonary disease: do newer metrics allow for disease modification?". Proc Am Thorac Soc. 4 (7): 507–511. doi:10.1513/pats.200701-013FM. PMID 17878462.